KROS - Dinamika pendapatan YoY sajrone rolas wulan kepungkur Keros Corp

Logo grafis Keros Corp (KROS)

The efficiency of Keros Therapeutics (KROS) in the race for FDA approval within the hematology segment determines its success, as clearly demonstrated by the rolling 12-month YoY revenue growth chart on GURU.Markets, where the -82.80 level reflects the current magnitude. Patent barriers and high testing costs bolster the fundamentals, while the operating model relies on outsourcing protein synthesis to minimize capital expenditures.

KROS Keros Therapeutics Inc: Wutah dodolan YoY sajrone rolas wulan kepungkur ing interval 11.02.2024 - 18.11.2026

kerostx.com (KROS) - rincian metrik lan laporan keuangan

- rega saham lan konsensus proyeksi valuasi:
Analisis kabeh metrik perusahaan:KROS (Keros Pharma)
Produk seri Keros Therapeutics

This indicator reflects the dynamics of operating revenues over a rolling year, utilizing daily interpolation to track the actual speed of business scaling without gaps between reports. For Keros Therapeutics (KROS), which is developing therapies for rare diseases, the rolling annual growth in sales revenue serves as a key marker for the commercialization of its scientific portfolio and the sustainability of management's strategy.

Karo sapa Keros Therapeutics saingan

VRTX (Vertex Pharmaceuticals Inc.) - Wutah dodolan taun lumaku|Alnylam Pharmaceuticals - Wutah dodolan YoY (TTM)|Dinamika pendapatan YoY sajrone rolas wulan kepungkur INSM (Insmed Incorporated)|UTHR: Wutah dodolan YoY (TTM)|BioMarin Pharmaceutical Inc. (BMRN) - Wutah dodolan YoY (TTM)|Wutah dodolan YoY sajrone rolas wulan kepungkur BridgeBio Pharma Inc|Wutah pendapatan YoY sajrone 12 wulan kepungkur BGM Group Ltd (BGM)|Wutah dodolan YoY sajrone rolas wulan kepungkur cogentbio.com (COGT)|Wutah pendapatan YoY sajrone 12 wulan kepungkur Xeris Biopharma XERS|Wutah dodolan YoY (TTM) ARCT (arcturusrx.com)|Wutah dodolan YoY (TTM) Eton Pharmaceuticals, Inc. ETON|KMDA - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah dodolan taun lumaku FULC|ABEO: Wutah dodolan YoY (TTM)|Wutah pendapatan taun lumaku Mereo BioPharma Group PLC (MREO)|Wutah pendapatan YoY sajrone 12 wulan kepungkur PLX|Pliant Therapeutics (PLRX) - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur Applied Therapeutics (APLT)|Rein Therapeutics Inc - Wutah dodolan YoY sajrone 12 wulan kepungkur|Wutah dodolan YoY (TTM) GELS (Gelteq)|Dinamika pendapatan YoY sajrone rolas wulan kepungkur AYTU|CMMB - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah pendapatan taun lumaku srxhealth.com|PLRZ (Polyrizon) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Aeterna Zentaris (AEZS) - Wutah dodolan YoY (TTM)|CYTH (Cyclo Therapeutics) - Wutah dodolan YoY (TTM)|INZY: Dinamika pendapatan YoY sajrone rolas wulan kepungkur|Wutah dodolan YoY (TTM) RPHM|CSCI (COSCIENS Biopharma) - Dinamika pendapatan YoY sajrone rolas wulan kepungkur